Noureldien H E Darwish (Noureldien He Darwish)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 12

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Transforming Growth Factor

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Noureldien H E Darwish, Khaled A Hussein, Khaled Elmasry, Ahmed S Ibrahim, Julia Humble, Mohamed Moustafa, Fatma Awadalla, Mohamed Al-Shabrawey
Bone Morphogenetic Protein-4 Impairs Retinal Endothelial Cell Barrier, a Potential Role in Diabetic Retinopathy. Cells 12 (9) (2023)
Noureldien H E Darwish, Khaled A Hussein, Khaled Elmasry, Ahmed S Ibrahim, Julia Humble, Mohamed Moustafa, Fatma Awadalla, Mohamed Al-Shabrawey
Bone Morphogenetic Protein-4 Impairs Retinal Endothelial Cell Barrier, a Potential Role in Diabetic Retinopathy. Cells 12 (9) (2023)
Noureldien H E Darwish, Khaled A Hussein, Khaled Elmasry, Ahmed S Ibrahim, Julia Humble, Mohamed Moustafa, Fatma Awadalla, Mohamed Al-Shabrawey
Bone Morphogenetic Protein-4 Impairs Retinal Endothelial Cell Barrier, a Potential Role in Diabetic Retinopathy. Cells 12 (9) (2023)
Ozlem Ozen Karakus, Noureldien H E Darwish, Thangirala Sudha, Taher A Salaheldin, Kazutoshi Fujioka, Peter C Taylor Dickinson, Brian Weil, Shaker A Mousa
Correction: Karakus et al. Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult. Biomedicines 2021, 9 , 1713. Biomedicines 10 (6) (2022)
John Paul Sese Tosoc, Olga Macas Nuñeza, Thangirala Sudha, Noureldien H E Darwish, Shaker A Mousa
Anticancer Effects of the Corchorus olitorius Aqueous Extract and Its Bioactive Compounds on Human Cancer Cell Lines. Molecules (Basel, Switzerland) 26 (19) (2021)
Thangirala Sudha, Kavitha Godugu, Noureldien H E Darwish, Tipu Nazeer, Shaker A Mousa
Novel Polyethylene Glycol-Conjugated Triazole Derivative with High Thyrointegrin αvβ3 Affinity in Acute Myeloid Leukemia Management. Cancers 13 (16) (2021)
Ali H El-Far, Taher A Salaheldin, Kavitha Godugu, Noureldien H E Darwish, Shaker A Mousa
Thymoquinone and its nanoformulation attenuate colorectal and breast cancers and alleviate doxorubicin-induced cardiotoxicity. Nanomedicine (London, England) (2021)
Ozlem Ozen Karakus, Noureldien H E Darwish, Thangirala Sudha, Taher A Salaheldin, Kazutoshi Fujioka, Peter C Taylor Dickinson, Brian Weil, Shaker A Mousa
Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult. Biomedicines 9 (11) (2021)
Ali H El-Far, Kavitha Godugu, Taher A Salaheldin, Noureldien H E Darwish, Amna A Saddiq, Shaker A Mousa
Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer. Biomedicines 9 (8) (2021)
Mohamed Nadjib Boukhatem, Thangirala Sudha, Noureldien H E Darwish, Henni Chader, Asma Belkadi, Mehdi Rajabi, Aicha Houche, Fatma Benkebailli, Faiza Oudjida, Shaker A Mousa
A New Eucalyptol-Rich Lavender (Lavandula stoechas L.) Essential Oil: Emerging Potential for Therapy against Inflammation and Cancer. Molecules (Basel, Switzerland) 25 (16) (2020)
Noureldien H E Darwish, Thangirala Sudha, Kavitha Godugu, Dhruba J Bharali, Osama Elbaz, Hasan A Abd El-Ghaffar, Emad Azmy, Nahla Hamed Anber, Shaker A Mousa
Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia. Molecules (Basel, Switzerland) 24 (11) (2019)
Nahla Hamed Anber, Ahmed H El-Sebaie, Noureldien H E Darwish, Shaker A Mousa, Sameh S Shamaa
Prognostic value of some inflammatory markers in patients with lymphoma. Bioscience reports 39 (3) (2019)